More than half of diabetic patients are affected by voiding dysfunction during the course of diabetes mellitus (DM) but why does this happen? Afferent neuropathy has been well documented to play a crucial role in diabetic cystopathy that is a consequence of DM. The function of sensory neurons within the bladder and throughout the body is controlled by modulating cellular synthesis of neuropeptides and the expression of ion channels in response to signals such as nerve growth factor (NGF). The level of NGF is decreased in DM that in turn leads to investigation of NGF replacement. Exogenous NGF administration and NGF gene therapy has been shown to prevent the behavioral and biochemical manifestations of diabetic sensory neuropathy in animals. However, the mechanism underlying functional alternation in sensory pathways responsible for diabetic cystopathy has not been elucidated. The investigators hypothesize that: 1) the bladder afferent neuron excitability is decreased in diabetes, and 2) NGF engineered replication defective herpes simplex virus (HSV) and regional infusion of NGF can prevent and reverse the diabetes-induced change in bladder afferent neuron and thereby improve bladder function. The scientific objectives of this grant are to: 1) Identify and characterize the cellular changes which occur in the diabetic bladder. Diabetic bladder afferent neuron excitability will be studied using patch-clamp recording techniques in streptozotocin induced diabetic rats and compared with control and sucrose-fed diuretic animals. 2) Develop novel molecular therapeutic strategies to treat diabetic cystopathy. NGF gene therapy in the diabetic bladder will be studied. Replication defective HSVvectors carrying the NGF gene will be injected into the bladder wall or NGF will be topically instilled into the bladder wall via an osmotic pump. By defining bladder afferent neuropathy of DM, one can offer the hope of prevention, reversal, and even cure of diabetic cystopathy with NGF gene therapy. This represents a high priority in the urologic care of diabetic patients.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK055045-04
Application #
6635135
Study Section
Special Emphasis Panel (ZRG1-UROL (01))
Program Officer
Mullins, Christopher V
Project Start
2000-09-15
Project End
2005-05-31
Budget Start
2003-07-01
Budget End
2004-05-31
Support Year
4
Fiscal Year
2003
Total Cost
$221,546
Indirect Cost
Name
University of Pittsburgh
Department
Surgery
Type
Schools of Medicine
DUNS #
004514360
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Kim, Dae Kyung; Jankowski, Ron J; Pruchnic, Ryan et al. (2009) In vitro and in vivo effect of lidocaine on rat muscle-derived cells for treatment of stress urinary incontinence. Urology 73:437-41
Wang, Chung Cheng; Nagatomi, Jiro; Toosi, K Khashayar et al. (2009) Diabetes-induced alternations in biomechanical properties of urinary bladder wall in rats. Urology 73:911-5
Gray, Margaret A; Wang, Chung-Cheng; Sacks, Michael S et al. (2008) Time-dependent alterations of select genes in streptozotocin-induced diabetic rat bladder. Urology 71:1214-9
Kim, Yong Tae; Kim, Dae Kyung; Jankowski, Ron J et al. (2007) Human muscle-derived cell injection in a rat model of stress urinary incontinence. Muscle Nerve 36:391-3
Torimoto, Kazumasa; Hirao, Yoshihiko; Matsuyoshi, Hiroko et al. (2005) alpha1-Adrenergic mechanism in diabetic urethral dysfunction in rats. J Urol 173:1027-32
Nishiguchi, Jun; Hayashi, Yukio; Chancellor, Michael B et al. (2005) Detrusor overactivity induced by intravesical application of adenosine 5'-triphosphate under different delivery conditions in rats. Urology 66:1332-7
Yoshimura, Naoki; Chancellor, Michael B; Andersson, Karl-Erik et al. (2005) Recent advances in understanding the biology of diabetes-associated bladder complications and novel therapy. BJU Int 95:733-8
Bennett, Nelson E; Kim, Jang H; Wolfe, Darren P et al. (2005) Improvement in erectile dysfunction after neurotrophic factor gene therapy in diabetic rats. J Urol 173:1820-4
Sasaki, Katsumi; Chancellor, Michael B; Goins, William F et al. (2004) Gene therapy using replication-defective herpes simplex virus vectors expressing nerve growth factor in a rat model of diabetic cystopathy. Diabetes 53:2723-30
Torimoto, Kazumasa; Fraser, Matthew O; Hirao, Yoshihiko et al. (2004) Urethral dysfunction in diabetic rats. J Urol 171:1959-64

Showing the most recent 10 out of 14 publications